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Abstract
Background Water-soluble phenolics from the oil palm
possess significant biological properties.
Purpose In this study, we aimed to discover the role of oil
palm phenolics (OPP) in influencing the gene expression
changes caused by an atherogenic diet in mice.
Methods We fed mice with either a low-fat normal diet
(14.6 % kcal/kcal fat) with distilled water, or a high-fat
atherogenic diet (40.5 % kcal/kcal fat) containing choles-
terol. The latter group was given either distilled water or
OPP. We harvested major organs such as livers, spleens
and hearts for microarray gene expression profiling anal-
ysis. We determined how OPP changed the gene expres-
sion profiles caused by the atherogenic diet. In addition to
gene expression studies, we carried out physiological
observations, blood hematology as well as clinical bio-
chemistry, cytokine profiling and antioxidant assays on
their blood sera.
Results Using Illumina microarrays, we found that the
atherogenic diet caused oxidative stress, inflammation and
increased turnover of metabolites and cells in the liver,
spleen and heart. In contrast, OPP showed signs of atten-
uating these effects. The extract increased unfolded protein
response in the liver, attenuated antigen presentation and
processing in the spleen and up-regulated antioxidant genes
in the heart. Real-time quantitative reverse transcription-
polymerase chain reaction validated the microarray gene
expression fold changes observed. Serum cytokine profil-
ing showed that OPP attenuated inflammation by modu-
lating the Th1/Th2 axis toward the latter. OPP also
increased serum antioxidant activity to normal levels.
Conclusion This study suggests that OPP may possibly
attenuate atherosclerosis and other forms of cardiovascular
disease.
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Introduction
Cardiovascular disease, together with atherosclerosis, is the
main cause of death in the world [1]. The oxidation of low-
density lipoproteins (LDL) has been accepted as an
important initial event in the development of atheroscle-
rosis [2]. Diets with plant-based foods such as fruit, veg-
etables, nuts and whole grains have been associated with a
significantly lower risk of cardiovascular disease [3, 4],
either through indirect effects due to the replacement of
high energy density foods with these typical low energy
density materials or through direct effects due to the plant
components present in these foods. Cardioprotection
afforded by these plant compounds is in part attributed to
their high antioxidant activities [5, 6], although actions
other than their direct antioxidant activities may be more
important [7, 8], such as their anti-inflammatory effects [9].
For example, phenolic compounds from soy [10], pome-
granate [11, 12], ginger [13, 14], red wine [15, 16] and olive
[17] were found to attenuate atherosclerosis either by LDL-
dependent mechanisms such as reducing LDL levels, inhib-
iting LDL oxidation and increasing antioxidant status or via
other LDL-independent mechanisms such as modulating
vascular function, blood pressure, enzyme systems and signal
transduction. Plant phenolics are thus promising candidates
for the prevention of cardiovascular disease [18].
The oil palm (Elaeis guineensis) fruit contains various
lipid-soluble phytochemicals such as carotenoids, toc-
opherols and tocotrienols, which possess significant anti-
oxidant properties [19–21]. During palm oil milling, large
volumes of aqueous vegetation liquor are produced. The
extraction of water-soluble materials from the oil palm
vegetation liquor recovers another class of phytochemicals
from the oil palm [22], namely oil palm phenolics (OPP).
OPP consist mainly of phenolic acids, including three
caffeoylshikimic acid isomers, protocatechuic acid and
p-hydroxybenzoic acid [23]. OPP have been shown to
display antioxidant properties and confer positive out-
comes on degenerative diseases in various animal models
without evidence of toxicity [24–26]. OPP showed signif-
icant biological activities against copper-mediated LDL
oxidation in vitro, promoted nitric oxide-mediated vascular
relaxation ex vivo, reduced blood pressure in a nitric oxide-
deficient rat model, prevented cardiac arrhythmia in coro-
nary arterial ligation rat models, as well as reduced
atherosclerotic plaques in blood vessels of atherogenic
diet-fed rabbits in vivo [24, 25]. These bioactivities confer
cardioprotection. In addition, we previously reported gene
expression changes caused by OPP in mice fed a low-fat
normal diet, in which the extract was indicated to have
novel health-promoting properties including possible
hepatoprotective, anti-dyslipidemic, anti-thrombotic and
caloric restriction mimetic effects [27].
In this study, we hypothesized that OPP can attenuate
atherosclerosis by modulating gene expression changes
caused by an atherogenic diet. We thus tested this
hypothesis by first feeding mice with either a low-fat
normal diet (14.6 % kcal/kcal fat) with distilled water
(ND ? DW group) or a high-fat atherogenic diet (40.5 %
kcal/kcal fat) containing cholesterol (0.15 % w/w). The
latter group was given either distilled water (AD ? DW
group) or OPP (AD ? OPP group). We harvested major
organs such as livers, spleens and hearts for microarray
gene expression profiling analysis. We then determined




OPP samples were prepared according to the methods
described in Sambanthamurthi et al. [22]. OPP contain
numerous phenolic acids. Three isomers of caffeoylshiki-
mic acid are major components of the extract [23]. Other
phenolic acids include caffeic acid, protocatechuic acid and
p-hydroxybenzoic acid. The detailed composition of OPP
is as described earlier [24].
Animal feeding and sample collection
All male inbred BALB/c mice that were designated for this
study were purchased from the Institute of Medical
Research, Kuala Lumpur, Malaysia, at around 5 weeks of
age just after weaning. All animal procedures were
approved by the Animal Care and Use Committee of the
University of Malaya, Kuala Lumpur, Malaysia. The ani-
mals were randomly assigned into cages (n = 5 per cage)
and acclimatized for 1 week, during which a standard chow
diet purchased from the University of Malaya and distilled
water were given ad libitum. At the start of the experiment,
the diet of the animals was changed to a custom-made low-
fat normal diet (58.2 % kcal/kcal carbohydrate, 27.2 %
kcal/kcal protein and 14.6 % kcal/kcal fat, including cel-
lulose, mineral mix, vitamin mix and DL-methionine) or a
custom-made high-fat atherogenic diet (40.5 % kcal/kcal
carbohydrate, 19.0 % kcal/kcal protein and 40.5 % kcal/
kcal fat, including 0.15 % w/w cholesterol, cellulose,
mineral mix, vitamin mix and DL-methionine) for 6 weeks
ad libitum. The ND ? DW group (n = 10) and the
AD ? DW group (n = 10) were supplemented with dis-
tilled water, while the AD ? OPP group (n = 10) was
supplemented with OPP, as drinking fluid ad libitum. The
phenolic content of the OPP given was around 1,500 ppm
gallic acid equivalent. Food and fluid were changed daily.
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During the animal feeding process, body weights were
monitored every week, while fluid intake was monitored
every day for 6 weeks. Food intake and fecal output were
monitored for seven consecutive days in the middle of the
designated feeding period, between week two to week
three. The mice were killed via euthanasia with diethyl
ether followed by exsanguination after 6 weeks of feeding
following an overnight food fast (with fluids still provided).
Blood samples were collected via cardiac puncture. Three
major organs including livers, spleens and hearts were
excised, blotted, weighed, snap-frozen in liquid nitrogen
and stored at -80 C until the total RNA extraction
process.
Hematology and clinical biochemistry analyses
Hematology and clinical biochemistry analyses were car-
ried out by the Clinical Biochemistry and Hematology
Laboratory, Department of Veterinary Pathology and
Microbiology, Faculty of Veterinary Medicine, Universiti
Putra Malaysia, Serdang, Selangor, Malaysia, using the
Animal Blood Counter Vet Hematology Analyzer (Horiba
ABX, France) and the Roche/Hitachi 902 Chemistry
Analyzer (Roche/Hitachi, Switzerland), respectively. Ali-
quots (200 lL) of whole blood samples (n = 4) were
stored in tubes containing ethylenediaminetetraacetic acid
for hematology analysis. In order to obtain sera, blood
samples were allowed to clot at room temperature for 2 h
before being centrifuged at 1,0009g for 5 min, after which
the supernatant layers were collected and stored at -20 C.
A portion (100 lL) of each serum sample (n = 6 per
group) was kept in aliquots for cytokine profiling and
antioxidant analysis. The remaining serum samples (around
200 lL per replicate) were subjected to clinical biochem-
istry analysis for eleven parameters. Two samples in the
ND ? DW group, two samples in the AD ? DW group
and three samples in the AD ? OPP group were excluded
due to blood lysis.
Total RNA extraction
Total RNA isolation from mouse organs was carried out
using the RNeasy Mini Kit (Qiagen, Inc., Valencia, CA)
and QIAshredder homogenizers (Qiagen, Inc., Valencia,
CA), preceded by grinding in liquid nitrogen using mortars
and pestles. The total RNA samples obtained were sub-
jected to NanoDrop 1000A Spectrophotometer (Thermo
Fisher Scientific, Waltham, MA) measurement for yield
and purity assessment. Integrity of the total RNA samples
was then assessed using the Agilent 2100 Bioanalyzer
(Agilent Technologies, Santa Clara, CA) and Agilent RNA
6000 Nano Chip Assay Kit (Agilent Technologies, Santa
Clara, CA). Four total RNA samples with the highest RNA
Integrity Numbers and 28S/18S rRNA ratios within each
condition were then selected for microarray studies.
Microarray gene expression analysis
Amplification of total RNA samples that were of high
yield, purity and integrity was carried out using the Illu-
mina TotalPrep RNA Amplification Kit (Ambion, Inc.,
Austin, TX). The biotinylated cRNA produced was then
hybridized to the Illumina MouseRef-8 Version 1 Expres-
sion BeadChip (Illumina, Inc., San Diego, CA), using the
Direct Hybridization Kit (Illumina, Inc., San Diego, CA).
Microarray hybridization, washing and scanning were
carried out according to the manufacturer’s instructions.
The raw gene expression data obtained are available at
Gene Expression Omnibus [28] (Accession number:
GSE30908).
Quality control of the hybridization, microarray data
extraction and initial analysis were carried out using the
Illumina BeadStudio software (Illumina, Inc., San Diego,
CA). Outlier samples were removed via hierarchical clus-
tering analysis provided by the Illumina BeadStudio soft-
ware and also using the TIGR MeV software (The Institute
for Genomic Research, Rockville, MD) [29]. A minimum
of three replicates per condition (with outliers removed)
was then considered for further analysis. For livers, spleens
and hearts of mice in the ND ? DW group, four replicates
were analyzed for each organ, respectively. On the other
hand, for livers, spleens and hearts of mice in the
AD ? DW and AD ? OPP groups, three replicates were
analyzed for each organ, respectively, with the exception of
livers in the AD ? DW group, in which four replicates
were analyzed. Three comparisons were made in this study,
with the first comparison to find out gene expression
changes caused by the atherogenic diet (AD ?
DW:ND ? DW), the second comparison to identify gene
expression changes caused by OPP (AD ? OPP:AD ?
DW) and the third to identify genes that were differentially
regulated by the two factors. The first two comparisons
were carried out separately before the third comparison
was made.
For the first two comparisons, gene expression values
were normalized using the rank invariant method and genes
that had Detection Levels of more than 0.99 in either
condition (control or treatment) were considered signifi-
cantly detected. To filter the data for genes that changed
significantly in terms of statistics, the Illumina Custom
error model was used and genes were considered signifi-
cantly changed at a |Differential Score| of more than 20,
which was equivalent to a P value of less than 0.01 [30].
The stringency of this filtering criterion was lowered to a
|Differential Score| of more than 13, which was equivalent
to a P value of less than 0.05, if less than 100 genes were
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found significantly changed. Since the results of this sta-
tistical analysis were to be used for functional analysis, it
was relevant to include more genes by using a lower
threshold to give statistical power to the functional analy-
sis. The genes and their corresponding data were then
exported into the Microsoft Excel software (Microsoft
Corporation, Redmond, WA) for further analysis. To cal-
culate fold changes, an arbitrary value of 10 was given to
expression values which were less than 10. Fold changes
were then calculated by dividing means of Signal Y
(treatment) with means of Signal X (control) if the genes
were up-regulated and vice versa if the genes were down-
regulated. Two-way (gene and sample) hierarchical clus-
tering of the significant genes was then performed using the
TIGR MeV software to ensure that the replicates of each
condition were clustered to each other. The Euclidean
distance metric and average linkage method were used to
carry out the hierarchical clustering analysis. Changes in
biological pathways and gene ontologies were assessed via
functional enrichment analysis, using the GenMAPP [31]
and MAPPFinder [32] softwares (University of California
at San Francisco, San Francisco, CA). The MAPPFinder
software ranks GenMAPPs (pathways) and gene ontologies
based on hypergeometric distribution. GenMAPPs and
gene ontologies that had Permuted P values of less than
0.01, Numbers of Genes Changed of more than or equal to
2 and Z Scores of more than 2 were considered significant.
A Permuted P value of less than 0.05 was used when genes
were selected using a |Differential Score| of more than 13,
in order to identify more GenMAPPs and gene ontologies
affected. Boxes colored yellow indicate genes that were
up-regulated, while those colored blue indicate genes that
were down-regulated. The fold changes are indicated next
to the boxes. Individual boxes that have different shadings
within them indicate the presence of multiple probes
(splice transcripts) within a single gene. Changes in regu-
latory networks were also analyzed through the use of the
Ingenuity Pathways Analysis software (Ingenuity Sys-
tems, Redwood City, CA). A network is a graphical rep-
resentation of the molecular relationships between genes or
gene products. Genes or gene products were represented as
nodes, and the biological relationship between two nodes
was represented as an edge (line). The intensity of the node
color indicates the degree of up-regulation (red) or down-
regulation (green). Nodes were displayed using various
shapes that represented the functional class of the gene
product. Edges were displayed with various labels that
described the nature of the relationship between the nodes.
In order to assess how OPP affected genes changed by
the atherogenic diet, the significantly changed genes
obtained in the first comparison were intersected with
significantly changed genes obtained in the second com-
parison in order to obtain a set of genes that were
significantly regulated by both factors (atherogenic diet and
OPP), hence the third comparison. The directions of fold
changes for genes in this intersecting set were then compared
in order to identify the number of genes that were differen-
tially regulated by both factors in terms of direction.
Real-time qRT-PCR validation
Two-step real-time quantitative reverse transcription-poly-
merase chain reaction (qRT-PCR) was carried out on six target
genes from the second comparison (Online Resource 1 in
Supplementary Material 1), selected to represent the different
organs used in the microarray experiments, using TaqMan
Gene Expression Assays (Applied Biosystems, Foster City,
CA). The same aliquots of total RNA samples used in the
microarray experiments were utilized for this analysis. Primer
and probe sets for the selected genes were obtained from the
ABI Inventoried Assays-On-Demand (Applied Biosystems,
Foster City, CA).
Briefly, reverse transcription to generate first-strand
cDNA from total RNA was carried out using the High-
Capacity cDNA Reverse Transcription Kit (Applied Bio-
systems, Foster City, CA). Real-time PCR was then carried
out on the first-strand cDNA generated using a 25 lL
reaction volume in an Applied Biosystems 7000 Real-Time
PCR System (Applied Biosystems, Foster City, CA) with
the following conditions: 50 C, 2 min, 1 cycle; 95 C,
10 min, 1 cycle; 95 C, 15 s and 60 C, 1 min, 40 cycles.
For gene expression measurements, reactions for each
biological replicate and non-template control (NTC) were
carried out in duplicates. For amplification efficiency
determination, reactions were carried out in triplicates.
Quality control of the replicates used, real-time qRT-PCR
data extraction and initial analysis were carried out using the
7000 Sequence Detection System software (Applied Biosys-
tems, Foster City, CA). A manual threshold of 0.6000 and an
auto baseline were applied in order to obtain the threshold
cycle (Ct) for each measurement taken. The threshold was
chosen as it intersected the exponential phase of the amplifi-
cation plots [33]. The criteria for quality control of the data
obtained include DCt less than 0.5 between technical repli-
cates and DCt more than 5.0 between samples and NTCs [34].
Relative quantification of the target genes of interest was
carried out using the qBase 1.3.5 software (Center for
Medical Genetics, Ghent University Hospital, Ghent, Bel-
gium) [35], which takes into account the calculations of
amplification efficiencies and multiple housekeeping
genes. Expression levels of target genes were normalized to
the geometric mean of three housekeeping genes, Sfrs9,
Guk1 and Hnrpab. Stability of these housekeeping genes
was assessed using the geNorm 3.5 software (Center
for Medical Genetics, Ghent University Hospital, Ghent,
Belgium) [36].
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Cytokine profiling
Cytokine profiling on serum samples was performed using
the Bio-Plex Suspension Array System (Bio-Rad Labora-
tories, Hercules, CA), available at the Faculty of Medicine,
University of Malaya. This assay was carried out using the
Bio-Plex Mouse Cytokine 23-Plex Cytokine Panel (Bio-
Rad Laboratories, Hercules, CA), which contains antibody-
conjugated beads (259 concentration) for 23 types of
mouse cytokines including IL-1a, IL-1b, IL-2, IL-3, IL-4,
IL-5, IL-6, IL-9, IL-10, IL-12 (p40), IL-12 (p70), IL-13,
IL-17, eotaxin, G-CSF (granulocyte colony-stimulating
factor), GM-CSF (granulocyte–macrophage colony-stimu-
lating factor), IFN-c (interferon-c), KC (keratinocyte-
derived chemokine), MCP-1 (monocyte chemoattractant
protein-1 or also known as monocyte chemotactic and
activating factor MCAF), MIP-1a (macrophage inflamma-
tory protein-1a), MIP-1b, RANTES (regulated on activa-
tion, normal T cell expressed and secreted) and TNF-a
(tumor necrosis factor-a). The kit also contains the neces-
sary components such as detection antibodies (259 con-
centration) and standards. The experiment was carried out
according to the manufacturer’s instructions. Each serum
sample (n = 6) was tested in duplicates. The data were
analyzed using the Bio-Plex Manager Version 4.0 software
(Bio-Rad Laboratories, Hercules, CA). Generation of
standard curves, averaging of duplicate fluorescence read-
ings of each serum sample, background subtraction with
the blank and calculation of concentration for each cyto-
kine were carried out by the Bio-Plex Manager software.
The averaged concentration readings were exported into
the Microsoft Excel software (Microsoft Corporation,
Redmond, WA) for statistical analysis.
Antioxidant analysis
Serum antioxidant analysis was carried out using four
assays, including the total phenolics content by Folin-Ci-
ocalteu reagent (TP-FCR) assay [37, 38], the ferric
reducing ability of plasma (FRAP) assay [39], the 2,2-
diphenyl-1-picrylhydrazyl (DPPH) scavenging activity
assay [40, 41] and the Trolox equivalent antioxidant
capacity (TEAC) assay [42]. All these assays were carried
out using the Infinite M200 microplate reader (Tecan,
Austria). Each serum sample (n = 6) was tested in dupli-
cates. Measurement settings and data acquisition were
carried out using the Magellan Version 6.2 software
(Tecan, Austria). Generation of standard curves, averaging
of duplicate absorbance readings of each sample, back-
ground subtraction with the blank, calculation of concen-
tration and statistical analysis for each assay were carried
out in the Microsoft Excel software (Microsoft Corpora-
tion, Redmond, WA).
Statistical analysis
Statistical analysis was carried out by using the two-tailed
unpaired Student’s t test available in the Microsoft Excel
software (Microsoft Corporation, Redmond, WA) unless
otherwise stated. Differences with P values of less than
0.05 were considered statistically significant.
Results
Physiology and pathology studies on mice
The body weights of mice steadily increased every week
throughout the 6 weeks of feeding, with animals in both the
AD ? DW and the AD ? OPP groups showing a higher
increase in weight gain compared to those in the
ND ? DW group (Online Resource 2a in Supplementary
Material 1). When the organ weights from these animals
were compared, mice in both the AD ? DW and the
AD ? OPP groups had increased liver weights compared
to those in the ND ? DW group (Online Resource 2b in
Supplementary Material 1). No significant differences in
terms of body weights and organ weights were found when
comparison was made only between the AD ? DW and
AD ? OPP groups. Also, no differences in terms of fluid
intake were found between the three groups (Online
Resources 2c and 2d in Supplementary Material 1). In the
AD ? OPP group, the volume of OPP taken was around
1.75 mL/day. Based on an average mouse weight of 25 g,
this would be equivalent to the consumption of about
350 mL (in volume) or 500 mg (in gallic acid equivalent
weight) of OPP by a 60 kg human, calculated based on the
body surface area normalization method [43]. Mice in both
the AD ? DW and AD ? OPP groups ingested less food
(Online Resources 2e and 2f in Supplementary Material 1)
and produced less feces (Online Resources 2g and 2h in
Supplementary Material 1) compared to the ND ? DW
group. No significant changes in terms of food intake and
fecal output were found when comparison was made only
between the AD ? DW and AD ? OPP groups, thus
indicating that the effects caused by OPP in mice fed the
atherogenic diet were due to the components of the extract
and not due to alterations in food intake.
Hematology analysis revealed that mice in both the
AD ? DW and AD ? OPP groups had a significant
increase in the levels of white blood cells, neutrophils and
lymphocytes compared to those in the ND ? DW group
(Online Resource 3 in Supplementary Material 1), indi-
cating an inflammatory response. OPP did not affect
hematology parameters in mice given the atherogenic diet.
Mice in both the AD ? DW and AD ? OPP groups
showed significant changes in terms of serum clinical
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biochemistry, including albumin (;), globulin (:), ratio of
albumin to globulin (;), total cholesterol (:), LDL (:) and
HDL (:) levels (Online Resource 3 in Supplementary
Material 1), when compared to those in the ND ? DW
group. OPP also did not cause significant changes in these
clinical biochemistry parameters measured, except for
normalizing the glucose level in mice on the atherogenic
diet similar to that of mice on the normal diet, probably due
to the presence of fruit sugars.
Microarray gene expression profiling of livers, spleens
and hearts
For gene expression profiling, Illumina microarrays were
used to study the effects of the atherogenic diet and OPP
(when mice were on the atherogenic diet) in three major
mouse organs, including the liver, spleen and heart. Genes
considered significantly changed were further subjected to
two-way (gene and sample) hierarchical clustering using
the TIGR MeV software to ensure that the replicates of
each condition were clustered to each other. Online
Resource 4 in Supplementary Material 1 shows an example
of the two-way hierarchical clustering analysis carried out
on genes significantly changed by OPP in the liver.
Using a |Differential Score| of more than 20, which was
equivalent to a P value of less than 0.01, the number of
genes significantly changed by the atherogenic diet was
highest in the liver (2,593 up-regulated and 451 down-
regulated), followed by the spleen (990 up-regulated and
534 down-regulated) and the heart (1,441 up-regulated and
991 down-regulated). The number of genes significantly
changed by OPP was highest in the spleen (327 up-regu-
lated and 249 down-regulated), followed by the liver (35
up-regulated and 84 down-regulated) and the heart (19 up-
regulated and 13 down-regulated). In the second compar-
ison, as the heart showed the least number of genes
significantly changed (32 genes) and thus would not give
much information in further functional enrichment analy-
sis, we reduced the stringency by filtering for significantly
changed genes with a |Differential Score| of more than 13,
which was equivalent to a P value of less than 0.05. This
yielded 132 significantly changed genes in the heart (79 up-
regulated and 53 down-regulated). The lists of genes,
GenMAPPSs and gene ontologies significantly changed by
the atherogenic diet in these mouse organs are provided in
Supplementary Material 2, while those significantly chan-
ged by OPP are given in Supplementary Material 3.
The atherogenic diet increased the turnover of metabolites
in the liver, as shown by an up-regulation of genes involved in
the generation of precursor metabolites (anabolism) and
energy (catabolism). It was also evident that genes involved in
fatty acid beta oxidation, the tricarboxylic acid cycle and the
electron transport chain were up-regulated, thus suggesting an
increase in energy production due to the utilization of extra fat.
In addition, the turnover of liver tissues was evident, from the
up-regulation of nuclear receptors that stimulate hepatocyte
growth such as Hnf4a (FC 2.57) (Online Resource 5a in
Supplementary Material 1) and cytochrome c oxidases,
complement genes and caspases involved in cell death (Online
Resource 5b in Supplementary Material 1). Not unexpectedly,
genes involved in cholesterol biosynthesis were down-regu-
lated (Online Resource 5c in Supplementary Material 1).
Genes involved in the immune response were also up-regu-
lated by the atherogenic diet in the spleen, such as those reg-
ulated by tumor necrosis factor-alpha (Tnfa) (although Tnfa
itself was not regulated) and signal transducer and activator of
transcription 3 (Stat3) (FC 1.59) (Online Resource 6a in
Supplementary Material 1). In addition, the apoptotic process
was up-regulated. On the other hand, genes down-regulated by
the atherogenic diet include those regulated by the tumor
suppressor Tp53 (FC -1.53) (Online Resource 6b in Sup-
plementary Material 1) and transforming growth factor-beta
(Tgfb1) (FC -2.33). Tp53 is anti-proliferative, while Tgfb1 is
anti-inflammatory. The up-regulation of Tnfa and Stat3,
coupled with the down-regulation of Tp53 and Tgfb1, suggests
the up-regulation of an inflammatory response toward the
atherogenic diet in the spleen. In the heart, the atherogenic diet
increased the expression of genes involved in fatty acid beta
oxidation, proteasomal degradation, heme biosynthesis, as
well as inflammation, including those regulated by Tnfa
(although Tnfa itself was not regulated), cyclic adenosine
monophosphate response element-binding protein (Crebbp)
(FC 7.15) and Jun oncogene (FC 1.67), which is part of acti-
vator protein-1 (Ap-1) (Online Resource 7a in Supplementary
Material 1). Down-regulated genes were found to be involved
in glycolysis, circadian rhythm, muscle development and anti-
inflammatory networks, such as those regulated by sirtuin 1
(Sirt1) (FC -2.03) and Tgfb1 (FC -6.65) (Online Resource
7b in Supplementary Material 1).
In livers of mice belonging to the AD ? OPP group,
genes involved in the unfolded protein response were
up-regulated (Fig. 1a) compared to the AD ? DW group.
Down-regulation of genes involved in endogenous antigen
presentation, fatty acid metabolism, arylsulfatase activity,
reduced nicotinamide adenine dinucleotide (NADH)
dehydrogenase (ubiquinone) activity and oxidoreductase
activity was also observed, indicating a down-regulation of
the inflammatory response and energy production. Com-
pared to the AD ? DW group, genes up-regulated in
spleens of mice in the AD ? OPP group were those
involved in carbohydrate metabolism, glucose metabolism,
glutathione metabolism as well as cytoskeleton organiza-
tion and biogenesis. Genes down-regulated by OPP in
spleens of mice are involved in antigen presentation
(Fig. 1b), apoptosis, B cell receptor signaling, defence
response, genes specific to blood and lymph tissues, heme
448 Eur J Nutr (2013) 52:443–456
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biosynthesis, immune response, regulation of apoptosis,
T-cell activation and differentiation as well as T-cell
receptor signaling. In hearts of mice, genes up-regulated by
OPP include those involved in antioxidant activities
(Fig. 1c), circadian exercise and nucleosome assembly.
Down-regulated genes, on the other hand, are involved in
electron transport and signaling as well as cell proliferation
and migration.
In order to assess how OPP affected genes changed by
the atherogenic diet, the significantly changed genes
obtained in the first comparison were intersected with
significantly changed genes obtained in the second com-
parison to obtain a set of genes, which was significantly
regulated by both factors (atherogenic diet and OPP). This
comparison is given in Supplementary Material 4. The
percentages of genes that were differentially regulated by
both factors in terms of direction were then calculated, with
the results for the liver, spleen and heart being 89.87 (71
out of 79 genes), 46.21 (67 out of 145 genes) and 58.46 %
(38 out of 65 genes), respectively. A majority ([50 %) of
the genes regulated by OPP in the different organs thus
showed a difference in regulation direction when compared
Fig. 1 Genes regulated by OPP in the liver, spleen and heart. a Genes
up-regulated in the liver unfolded protein response network. Genes
involved in the unfolded protein response up-regulated by OPP
include Tra1 and Vcp. b Genes down-regulated by OPP in the spleen
antigen presentation network. Genes encoding MHC II molecules
such as those belonging to the HLA-D family, genes of antigenic
markers such as Cd74, Cd82, Cd83 and Cd86 as well as genes
encoding chemokines such as Ccl5, Ccl19, Cxcl9 and Xcl1 were
down-regulated by OPP. The down-regulation of genes encoding
MHC II molecules could be caused by the down-regulation of C2ta.
c Genes up-regulated by OPP in the heart antioxidant pathway. Genes
involved in antioxidant activity such as Gpx1 and Mgst1 were up-
regulated by OPP
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to the atherogenic diet. Also, the highest percentage of
change was found in the liver, while the lowest percentage
of change was found in the spleen. Online Resource 8 in
Supplementary Material 1 shows a diagram to compare the
fold change direction of genes significantly changed by the
atherogenic diet and OPP, using the liver as an example.
Real-time qRT-PCR validation
To confirm the microarray results, the expression levels of six
target genes were measured using real-time quantitative
reverse transcription-polymerase chain reaction (qRT-PCR).
As the focus of this study was more to identify the changes
caused by OPP rather than those caused by the atherogenic
diet, genes chosen for real-time qRT-PCR were from the
second comparison (AD ? OPP:AD ? DW). The direction
and magnitude of fold changes obtained from the real-time
qRT-PCR technique quantified by the qBase software [35]
were comparable to those obtained from the microarray
technique (Online Resource 9a in Supplementary Material 1).
Correlation of fold changes obtained by the two gene
expression profiling techniques was high (R2 = 0.9920)
(Online Resource 9b in Supplementary Material 1).
Cytokine profiling and antioxidant analysis of blood
serum samples
For serum cytokine profiling, the levels of eotaxin were sur-
prisingly high for all the animals (Fig. 2). This may be caused
by the exposure of the animals to the non-sterile environment
as they were not maintained in a specific pathogen-free
facility. Although IL-9 was also present in the multiplex
cytokine panel used, it was not detected in any of the blood
serum samples tested. For those on the atherogenic diet, there
was a significant decrease in IL-12 (p40) and a significant
increase in IL-13 in the AD ? OPP group when compared to
the AD ? DW group (Fig. 2). The antioxidant analysis car-
ried out on the serum samples showed that for the AD ? DW
group, there was a significant decrease in antioxidant capacity
compared to the ND ? DW group, which indicates a higher
oxidative stress (Fig. 3). The AD ? OPP group, on the other
hand, showed almost similar antioxidant capacity when
compared to the ND ? DW group, thus indicating that the
antioxidant resistance of mice supplemented with OPP was
still high, although they were also given the atherogenic diet.
Discussion
Effects of atherogenic diet
When livers of mice in the AD ? DW group were com-
pared to those in the ND ? DW group, the fatty acid beta
oxidation process was found to be up-regulated, presum-
ably to metabolize extra fatty acids obtained from the
atherogenic diet. When challenged with the atherogenic
diet, the liver thus adjusts its metabolic processes in rela-
tion to lipid metabolism and energy production [44].
Nuclear receptors involved in tissue growth and genes
involved in cell death were also up-regulated in the present
study, thus suggesting that the atherogenic diet triggered
hepatic inflammatory reprogramming and liver regenera-
tion in the mice. This also explains the enlargement of
livers that was observed in these animals. An example of a
nuclear receptor up-regulated by the atherogenic diet in the
present study is the hepatocyte nuclear factor 4-alpha
(Hnf4a) (FC 2.57), which was also found to be up-regu-
lated when ApoE3Leiden (E3L) mice (which have lipid
profiles resembling those of humans) were fed an athero-
genic diet [45]. Among the genes involved in cell death
that were up-regulated in the present study were those
encoding cytochrome c oxidases belonging to the mito-
chondrial electron transport chain, complement genes and
caspases. The up-regulation of these genes suggests that
cell death occurred via apoptosis as a result of comple-
ment-mediated cell damage. Interestingly, Recinos et al.
[46] also showed that induction of the complement pathway in
the liver was associated with lesion development in athero-
sclerosis-prone LDL receptor-deficient (LDLr-/-) mice when
they were fed a high-fat Western style diet. As the atherogenic
diet provided dietary cholesterol that further increased cho-
lesterol levels in the blood circulation, genes involved in
hepatic cholesterol biosynthesis were down-regulated in this
study. This observation was not unexpected as de novo cho-
lesterol biosynthesis is down-regulated when cholesterol is
available from dietary intake [44, 47].
The immune system has long been implicated in ath-
erosclerosis [48–50], due to the presence of inflammation.
In response to the atherogenic diet, the spleen showed an
up-regulation in the production and turnover of immune
cells in the present study. A network significantly up-reg-
ulated involved the Stat3 gene (FC 1.59). It is interesting to
note that the Stat3 gene was discovered because of its role
in the acute phase response and that this is the only
capacity in which its function in vivo can be clearly
ascribed to its activity as a transcription factor [51].
Although apoptosis was up-regulated in this study, the
tumor suppressor Tp53 (FC -1.53) and other genes linked
to it were down-regulated. Together with the up-regulation
of the Stat3 network and apoptosis, the down-regulation of
the tumor suppressor Tp53 implies that the atherogenic diet
caused an increased turnover of immune cells in the spleen.
This thus explains the increased production and deploy-
ment of immune cells in the blood circulation, which may
further exacerbate the inflammatory effects of the athero-
genic diet.
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Fig. 2 Results of cytokine
profiling on blood serum
samples from mice. #P \ 0.05;
n = 6. Values are
means ± SEM
Fig. 3 Results of antioxidant analysis on blood serum samples from mice. a TP-FCR. b FRAP. c DPPH. d TEAC. #P \ 0.05 versus Normal
Diet ? Distilled Water; n = 6. Values are means ± SEM
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This study also revealed that two important networks
were regulated by the atherogenic diet in the heart, with the
first involving an up-regulated Jun oncogene (FC 1.67) and
the second involving a down-regulated Tgfb1 (FC -6.65).
The JUN protein forms part of the transcription factor
activator protein-1, which is pro-inflammatory as it has
been implicated in oxidative stress [52]. Binding sites of
the redox-regulated transcription factor activator protein-1
are located in the promoter region of a large variety of
genes that are directly involved in the pathogenesis of
diseases, including atherosclerosis. Activation of Jun via
Jun amino-terminal kinase (Jnk) in response to various
forms of stress causes arterial injury [53] and heart disease
[54–59]. The down-regulation of the Tgfb1 gene by the
atherogenic diet in the present study also implies a pro-
inflammatory response toward the diet in the heart. This is
because Tgfb is anti-inflammatory in atherosclerosis [60],
as it plays an important role in the maintenance of normal
blood vessel structure, and defects in this gene have been
linked to a range of cardiovascular syndromes including
loss of healthy vessel architecture and aneurysm [61].
Microarray profiling carried out by Tabibiazar et al. [62] on
the aortas of apolipoprotein E-deficient (apoE-/-) mice on
a high-fat diet compared with control C57BL/6J and C3H
mice across time also showed a decreased expression of an
isoform of Tgfb.
In the present study, preliminary physiology studies
carried out during animal feeding in order to identify the
effects of the atherogenic diet on the well-being of mice
showed several adverse effects of the diet, which include
increases in inflammation and oxidative stress, similar to
the observations found in previous studies [63–65].
Effects of OPP
In the livers of mice belonging to the AD ? OPP group,
genes up-regulated when compared to those of mice
belonging to the AD ? DW group were found to be
involved in the unfolded protein response. These genes
include Herpud1 (homocysteine-inducible, endoplasmic
reticulum stress-inducible, ubiquitin-like domain member
1) (FC 1.51), Tra1 (tumor rejection antigen gp96) (FC
1.35) and Vcp (valosin containing protein) (FC 1.23). The
unfolded protein response can be promoted by the buildup
of unfolded proteins in the endoplasmic reticulum, and it
constitutes a mechanism to reduce this burden. The
unfolded protein response acutely reduces translation of
new proteins, followed by increased expression of chap-
erones to aid folding of existing proteins and enhanced
elimination of proteins that cannot be refolded [66].
Endoplasmic reticulum stress responsive genes have been
suggested to be a protective response to protein unfolding
or protein damage resulting from cellular stress signals. In
addition, accumulation of oxidatively modified proteins
can elicit cellular damage and this is curtailed under nor-
mal conditions by intracellular protein degradation systems
such as the ubiquitin–proteasome system [67]. Thus, OPP
may help to reduce the amount of damaged proteins caused
by the atherogenic diet in the liver.
Transketolase (Tkt), which controls the non-oxidative
branch of the pentose phosphate pathway, provides reduced
nicotinamide adenine dinucleotide phosphate (NADPH) for
biosynthesis and reducing power of several antioxidant
systems [68]. It was up-regulated in the spleens of mice by
OPP (FC 1.85), together with glucose-6-phosphate dehy-
drogenase (X-linked) (G6pdx) (FC 3.59) and phosphoglu-
conate dehydrogenase (Pgd) (FC 2.82), all of which are
involved in the pentose phosphate pathway. The products
of the pentose phosphate pathway are important for the
biosynthesis of purine and for stimulating antioxidant
response pathways in conjunction with the action of dietary
phenolic antioxidants. This may also explain the up-regu-
lation of antioxidant genes including Mgst1 (microsomal
glutathione S-transferase 1) (FC 1.79), Mgst2 (microsomal
glutathione S-transferase 2) (FC 3.08), Gsr (glutathione
reductase 1) (FC 2.49) and Gstm1 (glutathione S-transfer-
ase, mu 1) (FC 1.89) in the spleens of mice given OPP.
Genes encoding MHC molecules such as H2-Ab1 (FC
-2.32) and H2-Eb1 (FC -2.36), which have been impli-
cated in atherosclerosis [62], were down-regulated in the
spleens of mice, thus suggesting that OPP was able to
attenuate the inflammatory response brought about by the
atherogenic diet. Activated macrophages and smooth
muscle cells express class II histocompatibility antigens
such as HLA-DR that allow them to present antigens to
T cells, which cause atherosclerosis [69]. The gene
expression of MHC II molecules is transcriptionally regu-
lated by the class II transcriptional activator (CIITA or
C2ta) (FC -2.58). CIITA activates the expression of MHC
II in all types of professional antigen-presenting cells
(macrophages, dendritic cells and B lymphocytes), of
which dendritic cells are the most potent among the three
[70]. In line with the down-regulation of MHCs, the C2ta
gene was down-regulated by OPP in mice fed the athero-
genic diet in the present study. A mechanism of anti-
inflammation brought about by antioxidants is through the
modulation of cytokine induction during inflammation
[71]. In agreement with this, cytokines and cytokine
receptors such as Ccl5, Ccl19 and Ccr7 were down-regu-
lated by OPP in the present study (FC -3.25, -2.89 and
-2.28, respectively). The CCR7 receptor present on the
surface of secondary lymphoid cells for instance functions
to attract dendritic cells, which migrate to secondary
lymphoid organs to present antigens for the activation of
naive T cells. Hence, the down-regulation of cytokines and
cytokine receptors by OPP in the present study suggests
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anti-inflammatory effects of the extract. Additionally,
cluster of differentiation (CD) antigenic markers such as
Cd3d, Cd24a, Cd59b, Cd72, Cd79a, Cd79b, Cd83 and
Cd86 were also down-regulated by OPP (FC -1.55, -1.37,
-3.02, -2.17, -1.97, -2.28, -3.14 and -2.00, respec-
tively). Cd83 and Cd86 are specific markers of mature
dendritic cells, which are up-regulated by oxidative stress
through a nuclear factor kappa-B-dependent mechanism
[70]. The down-regulation of MHC II genes and genes
encoding antigenic markers in this study further suggests
that OPP suppressed the inflammatory response associated
with the atherogenic diet, and this may constitute a
mechanism by which OPP ameliorates atherosclerosis.
In the hearts of mice belonging to the AD ? OPP group,
genes up-regulated when compared to those of mice
belonging to the AD ? DW group include antioxidant
genes, such as Mgst1 (microsomal glutathione S-transfer-
ase 1) (FC 1.71) and Gpx1 (glutathione peroxidase 1) (FC
1.24). These antioxidant genes are essential in the detoxi-
fication of carcinogens and the scavenging of reactive
oxygen species [72].
Despite the fact that mice in the AD ? OPP group did
not show significant changes in terms of body and liver
weights as well as the hematology and clinical biochem-
istry parameters when compared to mice in the AD ? DW
group, further cytokine profiling and antioxidant analysis
on the blood serum samples of these mice supported the in
vivo anti-inflammatory and antioxidant effects of the
extract. In contrast to the effects of OPP that down-regu-
lated hepatic cholesterol biosynthesis genes in mice fed the
normal diet found in our previous study [27], the extract
did not down-regulate this group of hepatic genes in mice
fed the atherogenic diet in the present study. This makes
sense as administration of the atherogenic diet has already
down-regulated cholesterol biosynthesis, and thus further
down-regulation of the pathway would be futile to prevent
atherosclerosis. On the other hand, OPP acted as an anti-
inflammatory agent and an antioxidant in mice given the
atherogenic diet to prevent oxidative stress and inflamma-
tion caused by the diet, and this is considered important in
the prevention of atherosclerosis and cardiovascular
disease.
As a component of the immune response, cytokines play
an important role in mediating the inflammatory response
in atherosclerosis. Atherosclerosis is normally associated
with cytokines that promote a Type 1 helper T-cell (Th1)
cellular immune response rather than a Type 2 helper
T-cell (Th2) humoral immune response [73]. The modu-
lation of the Th1/Th2 axis toward the latter may thus be
atheroprotective [74]. In mice belonging to the AD ? OPP
group, a decrease in the pro-inflammatory IL-12 (p40
subunit) cytokine and an increase in the anti-inflammatory
IL-13 cytokine in the sera were observed compared to the
AD ? DW group. This is believed to be an attenuation of
the inflammatory response toward atherosclerosis. IL-12 is
a cytokine of innate immunity, which is secreted by acti-
vated macrophages and dendritic cells, and is a key inducer
of cell-mediated immunity as it stimulates the production
of IFN-c, stimulates the differentiation of CD4 ? helper T
lymphocytes into Th1 cells as well as enhances the cyto-
lytic functions of activated natural killer cells and
CD8 ? cytolytic T lymphocytes [75]. It has been impli-
cated in atherosclerosis [74, 76, 77] and other inflammatory
diseases [78, 79]. IL-13 is a cytokine of adaptive immunity,
which is secreted by CD4 ? helper T lymphocytes (Th2
cells), and it inhibits macrophages and antagonizes IFN-c
[75]. In the present study, the anti-inflammatory effects
observed in the serum samples were consistent with the
gene expression changes seen in the spleens of mice given
OPP, which indicate attenuation of the inflammatory
response.
In addition, antioxidant analysis carried out on the
mouse blood serum samples showed that OPP restored the
antioxidant capacity of animals fed the atherogenic diet.
This is in line with the gene expression changes observed
in the liver, spleen and heart, in which antioxidant genes
were up-regulated by OPP. While the effects observed in
the present study are mainly attributed to phenolic com-
pounds, the possible effects of other components in OPP
cannot be discounted. What is important here is that the
extract in its entirety confers the positive outcomes repor-
ted in the present study.
Limitations of study
We acknowledge that the biggest limitation in this study is
the fact that BALB/c mice were used as biological models
for atherosclerosis, although rodents that are HDL animals
in general are not suitable as they do not mimic the human
atherosclerotic disease [80]. Nonetheless, microarray
studies in which normal rodent models were used to test for
the effects of high-fat or atherogenic diets have been car-
ried out before [62, 81]. It was thus reasoned that OPP
might still bring about gene expression changes in major
organs of BALB/c mice (which have intermediate sus-
ceptibility to atherosclerosis compared to the C57BL/6
mice) on an atherogenic diet. It was also easier to compare
the effects of the extract in this study with a previous one
involving the normal diet, as animals with the same genetic
background were used [27]. Thus, it would be interesting to
extend this study to other mouse models of atherosclerosis,
such as apoE-/- and LDLr-/- mice in the future.
Another limitation of this study is that fact that the aorta
as a primary target of atherosclerosis was not subjected to
atheroslerotic lesion and transcriptomic analyses to estab-
lish the anti-atherosclerotic mechanisms of OPP.
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Nevertheless, we have previously shown that OPP reduced
atherosclerotic plaques in the aortas of atherogenic diet-fed
rabbits [25]. When we first initiated this transcriptomic
analysis, however, no commercial whole genome rabbit
microarrays were available. Hence, we did not carry out
transcriptomic analysis on the aortas of rabbits. We then
decided to use whole genome mouse microarrays, as a first
step toward identifying the gene expression changes caused
by OPP. In relation to this, we previously published a
transcriptomic analysis study on the effects of OPP in mice
on a normal diet, in which we analyzed three particular
organs, liver, spleen and heart [27]. This present study was
not a standalone project but a part of this previous study, as
we were interested to explore the gene expression changes
caused by OPP when the mice were on an atherogenic diet,
rather than on a normal diet. During the course of the
present study, although we did intend to isolate aortas from
the mice for atherosclerotic lesion and transcriptomic
analyses, we faced technical difficulties in doing so due to
the size limitation of this mouse model. Moreover, the
animals that we had were not enough for pooling enough
samples to obtain sufficient total RNA. Thus, we decided to
carry out transcriptomic analysis on the three organs
instead, and identify the gene expression changes that may
provide initial clues to help explain how OPP confers
protection against the effects of an atherogenic diet.
Regardless, transcriptomic analysis on the aortas of any
biological model is deemed necessary in the future to
provide conclusive insights into the anti-atherosclerotic
mechanisms of OPP.
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